Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
4 USD +3.63% Intraday chart for Prelude Therapeutics Incorporated +11.42% -6.32%
05-07 Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PRELUDE THERAPEUTICS INCORPORATED Stock Prelude Therapeutics Incorporated
 212M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 49.18B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.11B
LONZA GROUP AG Stock Lonza Group AG
 40.37B
CELLTRION, INC. Stock Celltrion, Inc.
 28.85B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.09B
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. Charts Prelude Therapeutics Incorporated
  5. Sector Chart